info@seagull-health.com
SeagullHealth
语言:
search
new
Storage of Tevinofop alfa (Avlayah)
506
Article source: Seagull Pharmacy
Jun 22, 2026

Teverinofusp alfa is a lyophilized powder for injection. Its storage involves three different stages: unopened original packaging, after reconstitution, and after dilution. Each stage has strict requirements for temperature, humidity, and time.

I. Storage of Original Packaging

1. Temperature Requirements

(1) Must be stored under refrigeration at a temperature between 2°C and 8°C (36°F to 46°F).

(2) Do not freeze. Freezing will destroy the structural integrity of the active pharmaceutical ingredient.

2. Packaging Protection

(1) Should be kept in the original carton to protect from light.

(2) The original packaging provides effective light protection, preventing light exposure from affecting product quality.

3. Handling Prohibitions

(1) Do not shake. Shaking may cause protein aggregation or degradation.

(2) Before reconstitution, remove from the refrigerator and allow the vial to warm naturally at room temperature for 15 to 30 minutes.

(3) Do not use external heat sources (e.g., hot water, heaters) to accelerate warming.

II. Storage After Preparation

1. Storage After Reconstitution (not yet diluted)

(1) If not diluted immediately after reconstitution, it may be stored at room temperature (20°C to 25°C).

(2) The storage time must not exceed 4 hours.

(3) If not diluted within 4 hours, it must be discarded and not used further.

2. Storage After Dilution (already diluted in infusion bag)

(1) If not infused immediately after dilution, it should be stored under refrigeration (2°C to 8°C).

(2) The total refrigerated storage time must not exceed 24 hours.

(3) If stored for more than 24 hours, it must be discarded and not used further.

3. Visual Inspection of Solution

(1) After reconstitution, visually inspect the solution.

(2) An acceptable solution should be clear to slightly opalescent, colorless to pale brownish-yellow, and free of visible particles.

(3) If discoloration, turbidity, or visible particles are observed, it must be discarded.

III. Preparation Before Infusion

1. Time Limit After Removal from Refrigeration

(1) After removal from refrigeration, the diluted solution must be infused within 10 hours.

(2) Do not return to refrigeration after removal, to avoid temperature fluctuations that may affect stability.

2. Warming Before Infusion

(1) The refrigerated diluted solution should be allowed to reach room temperature before infusion, but the warming time counts toward the above 10‑hour limit.

(2) Do not use microwave ovens, hot water baths, or other heating methods to accelerate warming.

3. Discard Criteria

(1) Solutions meeting any of the following conditions should be discarded:

(2) Reconstituted solution stored at room temperature for more than 4 hours without dilution.

(3) Diluted solution refrigerated for more than 24 hours.

(4) Diluted solution removed from refrigeration and not infused within 10 hours.

(5) Solution with abnormal appearance.

(6) Any solution that has been frozen or shaken under any circumstances.

4. General Prohibitions for All Stages

(1) Freezing is prohibited at all stages (original packaging, after reconstitution, after dilution).

(2) Shaking is prohibited at all stages.

(3) For single use only. Any unused portion after reconstitution should be discarded and not saved for later use.

Note: For internal discussion among medical personnel only. For specific medication, please consult the attending physician. Drug information may change over time. For the latest information, we recommend adding a medical consultant or consulting for free online.
Recommended Articles
Storage conditions for Navepegritide
Navepegritide, as a biologic macromolecular drug, has active ingredients sensitive to temperature, light, and time, requiring strict management across three levels: refrigerated storage, room temperat...
Dosage and Administration of Navepegritide
Mastering the dose calculation, preparation operation, injection technique, and missed-dose management for Navepegritide is the key to ensuring smooth treatment.I. Dose Determination and Adjustment Pr...
Understanding and Managing Side Effects and Adverse Reactions of Idvynso
Understanding the possible side effects of Idvynso and mastering the correct countermeasures are key to ensuring safe and smooth treatment.I. Watch for serious adverse reactions that require immediate...
Healthy Lifestyle for Patients Taking Orforglipron
Taking Oglarian to control type 2 diabetes, establishing a healthy lifestyle is crucial for stabilizing blood glucose, reducing medication dosage, and delaying complications.I. Reasonable Dietary Mana...
Side effects and adverse reactions of tevinofop alfa (Avlayah)
During treatment with Tividnofusp alfa, various side effects may occur, involving hypersensitivity reactions, infusion-related reactions, hematologic abnormalities, and renal injury.I. Common Adverse ...
Storage of Carbachol and Brimonidine Tartrate Ophthalmic Solution (Yuvezzi)
Proper storage of carbachol and brimonidine tartrate ophthalmic solution (Yuvezzi) is an important prerequisite for ensuring stability of efficacy and guaranteeing safe medication use.I. Appropriate S...
Precautions for Use of Carbachol and Brimonidine Tartrate Ophthalmic Solution (Yuvezzi)
Safe use of carbachol and brimonidine tartrate ophthalmic solution requires not only proper instillation but also comprehensive attention to visual changes, operational procedures, and systemic effect...
Indications and Contraindications of Copper Histidinate (Zycubo)
Histidine copper (Zycubo), as a copper replacement therapy, has a specific range of applicable diseases, and there are also clear contraindications. Accurately mastering this information helps to avoi...
Related Articles
Contraindications and Special Populations of Brensocatib Tablets
The prescribing information for Brixocatib tablets indicates that there are no absolute contraindications, but careful assessment of risks and benefits is still required in patients with special physi...
Dosage and Administration of Isatuximab Injection (Sarclisa)
Sarclisa must be administered under the supervision of a healthcare professional, and the administration site must be equipped with immediately available emergency equipment and medical support to man...
Indications and Dosage of Tepotinib
Tepotinib is an oral MET tyrosine kinase inhibitor indicated for the treatment of non-small cell lung cancer harboring MET exon 14 skipping mutations.I. Indications and Patient Selection1. Applicable ...
Dosage and Administration of Zidesamtinib
Before the first administration of Ziditnib, the following baseline assessments must be completed: serum creatine phosphokinase level, electrocardiogram, blood electrolytes (potassium, magnesium, calc...
Indications and Dosage and Administration of Ripretinib
Ripretinib is a kinase inhibitor specifically indicated for adult patients with advanced gastrointestinal stromal tumors who have previously received three or more kinase inhibitors.I. Indications and...
Contraindications and Medication in Special Populations of Ripretinib
Ripretinib does not list any absolute contraindications in its prescribing information, but there are clear usage restrictions or risks for specific physiological states and populations.I. Clear Contr...
Adverse Reactions of Ripretinib
Unlike traditional inhibition that targets the active site of a single kinase, ripretinib modulates the kinase "switch" conformation to suppress aberrant kinase signaling of KIT and PDGFRA, ...
Contraindications and Medication in Special Populations of Etoricoxib
Etoricoxib is effective for pain relief, but due to its cardiovascular and gastrointestinal risks, there are clear contraindications for its use.I. Absolute contraindications: who must not use it1. Al...
New Drugs
Infigratinib(Truseltiq)
Infigratinib(Truseltiq)
Treatment of previously treated, unresectable locally advanced or metastatic...
Opicapone(Ongentys)
Opicapone(Ongentys)
Adjunctive treatment to levodopa/carbidopa for reducing "off" episodes in...
Deflazacort(Emflaza)
Deflazacort(Emflaza)
Treatment of Duchenne muscular dystrophy (DMD) in patients aged 2 years and...
Faricimab-svoa(Vabysmo)
Faricimab-svoa(Vabysmo)
Treatment of neovascular age-related macular degeneration, diabetic macular...
Counselling Service
Global Drug Search
Clinical Research Recruitment
Overseas Medical Treatment
Remote Consultations
Note: Our medical consultant will contact you as soon as possible. We promise to strictly protect your privacy.
Submit
Business
  • Core products
  • Antitumor drugs
  • General drug
  • Antiviral drugs
  • Biological agents
Contact Us 
  • haiousales@gmail.com
Welcome to consult
Seagull Pharmacy.,Ltd All rights reserved